
Dr Emil KendziorraFounder & CEO
In this interview, Emil Kendziora discusses the future of cryopreservation, longevity science, and the pursuit of life extension. He explains why he views cryostasis as a potential option for individuals facing terminal illness and how advances in medicine could expand future possibilities. Kendziora also shares his journey from practicing medicine to entrepreneurship and outlines his mission to make cryopreservation more accessible, affordable, and scientifically rigorous.
Founder Stats
- Health & Wellness
- Started 2020
- $50K-$250K/mo
- 11–50 team
- Berlin, Germany
About Dr Emil Kendziorra
Emil Kendziora is the founder and CEO of Tomorrow.Bio, a cryopreservation company focused on advancing cryostasis and longevity science in Europe. Trained as a medical doctor, he transitioned into entrepreneurship to explore technologies that could extend healthy lifespans and preserve future medical opportunities. Through Tomorrow.Bio, Kendziora works to increase awareness, accessibility, and scientific development within the emerging field of human cryopreservation.
Interview
June 12, 2026
What first inspired your interest in longevity and life extension?
Why did you move from medicine and research into entrepreneurship?
How did your previous startups prepare you for Tomorrow.Bio?
Why do you describe Tomorrow.Bio as your life's work?
What makes cryopreservation different from other longevity approaches?
How do you explain cryopreservation to someone hearing about it for the first time?
What are the biggest misconceptions about cryopreservation?

Many people think it belongs entirely in science fiction. In reality, preservation is already possible today. The challenge is future revival. We are very transparent about that. Nobody can currently bring a cryopreserved person back, but the goal is to create that possibility through future scientific progress.
How do you think about risk when discussing cryopreservation?

I never describe it as a guarantee. Cryopreservation is about improving your odds. If someone chooses burial or cremation, the chance of returning is effectively zero. Cryopreservation offers at least a possibility, and our job is to keep improving those odds through research, governance, and long-term planning.
What leadership lesson has helped you most as a founder?
Why do you focus more on mission than short-term profits?
How do you measure success for Tomorrow.Bio?
Why is affordability such an important goal?
Table Of Questions
Video Interviews with Dr Emil Kendziorra
The Startup Freezing Humans For Tomorrow - Interview with Dr Emil Kendziorra, CEO of Tomorrow.bio
Cite This Interview
Use this interview in your research, article, or academic work
Related Interviews

Kiran Mazumdar-Shaw
Founder & Executive Chairperson at Biocon
In this interview, Biocon founder and executive chairperson Kiran Mazumdar-Shaw discusses the pioneering of India's biotechnology sector, from launching an enzyme startup to building a…

Cobi Blumenfeld-Gantz
Co-Founder & CEO at Chapter
In this interview, Chapter co-founder and CEO Cobi Blumenfeld-Gantz discusses the company's rise to a $3 billion valuation in the senior health navigation market. He…

Mark Bertolin
CEO at Oscar Health
In this interview, Oscar Health CEO Mark Bertolini explains how technology, AI, and consumer choice can reshape the health insurance industry. He discusses the future…

Allison Ellsworth
Co-founder at Poppi
In this interview, Poppi co-founder Allison Ellsworth shares the journey of building a prebiotic soda brand from a kitchen counter experiment to a 1.95 billion…

Sam Altman
Co-founder & CEO at OpenAI
In this interview, OpenAI co-founder and CEO Sam Altman discusses the shifting dynamics of startup creation, the trajectory of model scaling laws, and the geopolitical…

Jamie Dimon
Chairman & CEO at JPMorgan Chase
In this interview, JPMorgan Chase Chairman and CEO Jamie Dimon discusses navigating macroeconomic tail risks, managing corporate bureaucracy, and building long-term financial resilience. Dimon addresses…